Global Markets and Manufacturing Technologies for Protein Drugs

Sep 2021| BIO021F| BCC Publishing
Report Overview

Report Highlights

The global protein drugs market should reach $394.2 billion by 2026 from $265.0 billion in 2021 at a compound annual growth rate (CAGR) of 8.3% for the forecast period of 2021 to 2026.

Report Includes

  • 37 data tables and 28 additional tables
  • An overview of the global markets and manufacturing technologies for protein drugs
  • Estimation of the market size and analyses of global market trends, with data from 2019 to 2020, estimates for 2021 with projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of the current and future market potential and quantification of protein drugs market based on type, manufacturing process and region
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
  • Detailed description of protein drugs, their classification and six main manufacturing technologies and information on recombinant deoxyribonucleic acid (rDNA) technology
  • Information on advancements in manufacturing technologies, new product launches of the industry and discussion on effect of biosimilars entry to the protein drugs market
  • Detailed analysis of the regulatory framework and policies and technological changes within the industry
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
  • Comprehensive company profiles of the leading players of the industry, including AbbVie Inc., Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Pfizer Inc. and Sanofi S.A.

Report Scope

This report will focus on protein drugs, classification and manufacturing technologies. The protein drugs market can be classified into peptide hormones, monoclonal antibodies, cytokines, therapeutic enzymes, blood factors, vaccines and peptide antibiotics. This report focuses on six techniques for manufacturing protein therapeutics, including fractionation from natural human/animal sources, microbial fermentation, cell culture, chemical synthesis, transgenics and embryonated eggs. The report focuses on each market and its applications, regulatory environment, latest trends and developments, drivers, restraints and challenges affecting the market.

The report covers company profiles for all the major companies and also company share analysis. This report also covers market projections to 2026 and relevant patent analysis. By geography, the market has been segmented into the United States, Europe and emerging markets. Emerging markets include India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand. For market estimates, data has been provided for the year 2019, 2020 (as base year) and forecast through 2026.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Global Markets and Manufacturing Technologies for Protein Drugs159 $5,500 Free
Chapter- 1: Introduction5Free DownloadFree
Chapter- 2: Summary and Highlights2$250Free
Chapter- 3: Therapeutic Proteins: Overview17$588Free
Chapter- 4: Regulatory Aspects7$242Free
Chapter- 5: New Developments13$450Free
Chapter- 6: Market Analysis of Protein Drugs by Type23$796Free
Chapter- 7: Market Analysis of Protein Drugs by Region17$588Free
Chapter- 8: Market Analysis of Protein Drugs by Manufacturing Process18$623Free
Chapter- 9: Competitive Landscape9$311Free
Chapter- 10: Market Dynamics5$173Free
Chapter- 11: Patent Analysis1$35Free
Chapter- 12: Company Profiles42$1,453Free
Published - May-2016| Analyst - Shalini Shahani Dewan| Code - BIO021E

Report Highlights

The global protein drugs market reached nearly $174.7 billion in 2015 and should reach nearly $248.7 billion by 2020 at a compound annual growth rate (CAGR) of 7.3% through 2020.

Report Includes

  • An overview of the markets for each major class of protein in the segments therapeutic monoclonal antibodies, cytokines, peptide hormones, vaccines, and blood products
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
  • Discussion covering the strength and weaknesses of each type of technology in light of the new technologies, growing competition, and changing customer needs
  • Examinations of current successes, including the size and sales forecast for each class in the next five years
  • Evaluation of challenges such as delivery methods and side effects
  • Consideration of issues regarding add-on products and patent protection
  • Company profiles of major players
Published - Oct-2013| Analyst - Shalini Shahani Dewan| Code - BIO021D

Report Highlights

The global protein therapeutics market reached $138.3 billion in 2012. This market is expected to decline to $136.7 billion in 2013 and then increase to nearly $179.1 billion in 2018, a compound annual growth rate (CAGR) of 5.6% over the five-year period from 2013 to 2018.

Report Includes

  • An overview of the markets for each major class of protein in the segments therapeutic monoclonal antibodies, cytokines, peptide hormones, vaccines, and blood products
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
  • Examinations of current successes, including the size and sales forecast for each class in the next five years
  • Discussion of challenges such as delivery methods and side effects
  • Consideration of issues regarding add-on products and patent protection
  • Comprehensive company profiles of major players.
Published - Oct-2008| Analyst - Amy Brock| Code - BIO021C

Report Highlights

  • The global market for protein drugs is expected to increase from $86.8 billion in 2007 to an estimated $95.2 billion in 2008 and $160.1 billion in 2013, a compound annual growth rate (CAGR) of 10.9%.
  • Peptide hormones generated $26.1 billion in 2007 and an estimated $27.9 billion in 2008. This segment should reach $50.4 billion in 2013, for a CAGR of 12.6%.
  • The antibodies segment was worth $15.0 billion in 2007. This is expected to increase to $18.1 billion in 2008 and $36.9 billion in 2013, for a CAGR of 15.4%.
Published - Jul-2000| Analyst - Rahul Jasuja| Code - BIO021B

Report Highlights

  • Protein drugs for human therapeutic use are a 1,000 metric ton industry-more than one billion grams of bulk proteins that garnered formulation sales, on average, of $27.80 per gram in 1999. This study estimates 1,048,859,344 grams of bulk drug proteins were produced worldwide in 1999. Approximately 1,150,573,386 grams will be produced worldwide in 2004, representing an overall 1.9% average annual (compound) growth rate from 1999 to 2004.
  • Recombinant biological methods provided only 0.1% of the worldwide total bulk drug protein production in 1999, but are projected to provide 0.6% of the total production in 2004.

Global Markets and Manufacturing Technologies for Protein Drugs

Single User License: $5500

Member Price: FREE

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS